Catalyst Wire Dossier Catalyst Wire Dossier

Pegozafermin

pegozafermin · 89bio, Inc.
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Pegozafermin, covering 2024-04-02 to 2026-07-07. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Severe Hypertriglyceridemia [Phase 3]

See pricing